RP-64477

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRP-64477
Drug Alias NameRP-64477
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcyl coenzyme A:cholesterol acyltransferase inhibitors
TargetsAcyl coenzyme A:cholesterol acyltransferase
Therapy Area/IndicationsHyperlipidemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsHyperlipidemias

Other Information

ATC CodeN/A
Related LinksN/A